Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2013

View Archived Issues

Boehringer Ingelheim patents new CCR2 receptor antagonists

Scientists elucidate factors necessary for platelet killing of P. falciparum

Takeda provides overview of activities from April-December 2012

Immune responses analyzed in infants administered an enterovirus vaccine

Bristol-Myers Squibb patents new Y4 receptor agonists

New PI3Kgamma and delta inhibitors disclosed by Infinity Pharmaceuticals and Intellikine

Scientists at Theracrine patent novel agents for cancer

Laboratorios del Dr. Esteve synthesizes novel sigma1-receptor ligands

Nanjing Molecular Research divulges new agents for HCV infection

GlaxoSmithKline: fourth quarter 2012 in review

First-in-human results of LNP-encapsulated siRNA therapy show promise in cancer patients

Albany Molecular Research out-licenses tubulin inhibitor

Champions Oncology receives on-time payment under Teva technology collaboration

TG Therapeutics opens expansion cohorts in trial of ublituximab

Catabasis Pharmaceuticals reports phase I data for CAT-1004

Synageva BioPharma begins phase III ARISE trial

UCB and Amgen decide not to pursue romosozumab program in fracture healing

Galenica provides update on regulatory processes for PA-21

Pediatric indication of Ixiaro approved in Europe

French group synthesizes new imino-sugar derivatives

Pfizer presents new GPR119 receptor agonists

Merck KGaA synthesizes novel FSH receptor agonists

Revlimid approved in China, gets priority review for new indication in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...